Coin flip chemo: study tests if patients will let a computer choose their treatment strength

This study looks at whether adults with acute myeloid leukemia (AML) who are not healthy enough for strong chemotherapy are willing to let a computer randomly assign them to either lower- or higher-intensity treatment. The goal is to see if this approach is acceptable to patients, which could help doctors learn which treatment intensity works best for this group. About 50 people will take part, and the main measure is how many agree to randomization.